PhaseV

Smarter Decisions. AI Optimized Trials.

Cambridge, United States · $65.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$65.0M
Last Round
$50.0M Series AMay 2025
Rounds
3

About

PhaseV is a Boston-based technology company that uses causal machine learning and generative AI, augmented by a large patient-level data lake, to help biopharma sponsors and CROs make faster and more accurate clinical development decisions. Its platform supports adaptive trial design, patient stratification, site selection, and portfolio optimization.

Summary

PhaseV is an Artificial Intelligence company based in Cambridge, United States. It has raised $65.0M in total across 3 rounds, most recently a $50.0M Series A round in May 2025. Investors include Exor Ventures, Viola FinTech and Accel.

Tech & App Stack

4 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AMay 2025
$50.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PhaseV on Indexed.vc
<a href="https://indexed.vc/companies/phasev"><img src="https://indexed.vc/api/badge/company/phasev" alt="PhaseV on Indexed.vc" width="260" height="76" /></a>